NGHIÊN cứu đặc điểm GIẢI PHẪU BỆNH và MIỄN DỊCH HUỲNH QUANG TRỰC TIẾP TRONG CHẨN đoán BỆNH DA BÓNG nước tự MIỄN

BỘ GIÁO DỤC VÀ ĐÀO TẠO BỘ Y TẾ ĐẠI HỌC Y DƯỢC THÀNH PHỐ HỒ CHÍ MINH -oOo - LÊ THỊ ÁI NHÂN NGHIÊN CỨU ĐẶC ĐIỂM GIẢI PHẪU BỆNH VÀ MIỄN DỊCH HUỲNH QUANG TRỰC TIẾP TRONG CHẨN ĐỐN BỆNH DA BĨNG NƯỚC TỰ MIỄN LUẬN VĂN BÁC SĨ NỘI TRÚ THÀNH PHỐ HỒ CHÍ MINH – NĂM 2021 BỘ GIÁO DỤC VÀ ĐÀO TẠO BỘ Y TẾ ĐẠI HỌC Y DƯỢC THÀNH PHỐ HỒ CHÍ MINH -oOo - LÊ THỊ ÁI NHÂN NGHIÊN CỨU ĐẶC ĐIỂM GIẢI PHẪU BỆNH VÀ MIỄN DỊCH HUỲNH QUANG TRỰC TIẾP TRONG CHẨN ĐỐN BỆNH DA BĨNG NƯỚC TỰ MIỄN NGÀNH: GIẢI PHẪU BỆNH MÃ SỐ: LUẬN VĂN BÁC SĨ NỘI TRÚ NGƯỜI HƯỚNG DẪN KHOA HỌC TS.BS TRẦN HƯƠNG GIANG THÀNH PHỐ HỒ CHÍ MINH – NĂM 2021 LỜI CAM ĐOAN Tơi xin cam đoan cơng trình nghiên cứu khoa học độc lập thân chỉa dẫn người hướng dẫn khoa học Các nội dung nghiên cứu trình bày luận văn không chép từ đâu Số liệu kết nghiên cứu hoàn toàn trung thực chưa sử dụng cơng bố cơng trình khác MỤC LỤC DANH MỤC TỪ VIẾT TẮT i DANH MỤC ĐỐI CHIẾU THUẬT NGỮ VIỆT- ANH iii DANH MỤC BẢNG v DANH MỤC BIỂU ĐỒ vii DANH MỤC CÔNG THỨC viii DANH MỤC SƠ ĐỒ .ix DANH MỤC HÌNH x ĐẶT VẤN ĐỀ CHƯƠNG 1: TỔNG QUAN TÀI LIỆU 1.1 Đại cương mô học da 1.1.1 Lớp thượng bì 1.1.2 Lớp bì 1.1.3 Lớp hạ bì 1.2 Khái quát BDBNTM 1.2.1 Định nghĩa phân loại BDBNTM 1.2.2 Cơ chế bệnh sinh BDBNTM 1.3 Nhóm bệnh Pemphigus 12 1.3.1 Pemphigus thông thường 12 1.3.2 Pemphigus (PF) 14 1.3.3 Pemphigus sùi (Pemphigus vegetens- PVe) 16 1.3.4 Pemphigus đỏ da (Pemphigus erythematosus- PE) 16 1.3.5 Pemphigus đặc hữu (Endemic pemphigus foliaceus- EPF) 17 1.3.6 Pemphigus IgA (Immunoglobulin A pemphigus- IAP) 18 1.3.7 Pemphigus cận u (Paraneoplastic pemphigus- PNP) 19 1.3.8 Pemphigus dạng herpes (Pemphigus herpetiformis- PH) 21 1.3.9 Pemphigus thuốc (DIP) 22 1.4 Nhóm pemphigoid 22 1.4.1 Pemphigoid bóng nước (Bullous pemphigoid- BP) 22 1.4.2 Pemphigoid niêm mạc (Mucous membrane pemphigoid-MMP) 25 1.4.3 Pemphigoid thai kỳ (Pemphigoid gestationis) 26 1.4.4 Ly thượng bì bóng nước mắc phải (EBA) 27 1.4.5 Bệnh IgA đường (Linear IgA disease- LAD) 28 1.4.6 Lupus ban đỏ hệ thống thể bóng nước (BSLE) 30 1.5 Viêm da dạng herpes (Dermatitis herpetiformis – DH) 32 1.6 Xét nghiệm DIF 33 1.6.1 Nguyên lý chung xét nghiệm DIF 33 1.6.2 DIF chẩn đốn bệnh da bóng nước tự miễn 34 CHƯƠNG 2: ĐỐI TƯỢNG VÀ PHƯƠNG PHÁP NGHIÊN CỨU 43 2.1 Đối tượng nghiên cứu 43 2.1.1 Tiêu chuẩn chọn bệnh vào mẫu nghiên cứu 43 2.1.2 Tiêu chuẩn loại trừ 46 2.2 Phương pháp nghiên cứu 46 2.2.1 Thiết kế nghiên cứu 46 2.2.2 Cách chọn mẫu nghiên cứu 46 2.2.3 Tiến trình nghiên cứu 46 2.3 Các biến số nghiên cứu 49 2.3.1 Các biến số mẫu nghiên cứu 49 2.3.2 Các biến số đặc điểm giải phẫu bệnh tổn thương 49 2.3.3 Các biến số đặc điểm lắng đọng KT tiêu nhuộm DIF 52 2.3.4 Chẩn đoán mô bệnh học 53 2.3.5 Chẩn đoán DIF 54 2.3.6 Chẩn đoán xác định 55 2.4 Y đức nghiên cứu 56 2.5 Thời gian địa điểm tiến hành nghiên cứu 56 CHƯƠNG 3: KẾT QUẢ NGHIÊN CỨU 57 3.1 Một số đặc điểm lâm sàng bệnh da bóng nước tự miễn 57 3.1.1 Tỷ lệ số lượng BDBNTM 57 3.1.2 Giới tính bệnh nhân 58 3.1.3 Tuổi bệnh nhân 59 3.2 Đặc điểm giải phẫu bệnh BDBNTM 60 3.2.1 Đặc điểm đại thể tổn thương da BDBNTM 60 3.2.2 Đặc điểm vi thể tổn thương tiêu H&E 64 3.3 Đặc điểm lắng đọng kháng thể DIF BDBNTM 69 3.3.1 Loại KT lắng đọng 69 3.3.2 Vị trí lắng đọng KT 71 3.3.3 Kiểu lắng đọng KT 72 3.3.4 Cường độ lắng đọng KT 73 3.4 Đánh giá tương hợp lâm sàng, mô bệnh học DIF chẩn đoán BDBNTM 76 3.4.1 Sự tương hợp lâm sàng, mô bệnh học DIF chẩn đoán BDBNTM 77 3.4.2 Sự tương hợp lâm sàng, mơ bệnh học DIF chẩn đốn bệnh nhóm pemphigus 77 3.4.3 Sự tương hợp lâm sàng, mô bệnh học DIF chẩn đốn BDBNTM thượng bì 80 CHƯƠNG 4: BÀN LUẬN 83 4.1 Một số đặc điểm lâm sàng bệnh da bóng nước tự miễn 83 4.1.1 Tỷ lệ số lượng BDBNTM 83 4.1.2 Giới tính bệnh nhân 86 4.1.3 Tuổi bệnh nhân 88 4.2 Đặc điểm giải phẫu bệnh BDBNTM 92 4.2.1 Đặc điểm đại thể tổn thương BDBNTM 92 4.2.2 Đặc điểm vi thể tổn thương tiêu H&E 101 4.3 Đặc điểm lắng đọng kháng thể DIF BDBNTM 107 4.3.1 Loại KT lắng đọng 107 4.3.2 Vị trí lắng đọng KT 113 4.3.3 Kiểu lắng đọng KT 115 4.3.4 Cường độ lắng đọng KT 117 4.4 Đánh giá tương hợp lâm sàng, mô bệnh học DIF chẩn đoán BDBNTM 119 4.4.1 Sự tương hợp lâm sàng, mơ bệnh học DIF chẩn đốn BDBNTM 119 4.4.2 Sự tương hợp lâm sàng, mô bệnh học DIF chẩn đốn bệnh nhóm pemphigus 122 4.4.3 Sự tương hợp lâm sàng, mô bệnh học DIF chẩn đốn BDBNTM thượng bì 125 CHƯƠNG 5: KẾT LUẬN 130 5.1 Một số đặc điểm lâm sàng bệnh da bóng nước tự miễn 130 5.2 Đặc điểm giải phẫu bệnh DIF BDBNTM 130 5.2.1 Đặc điểm đại thể tổn thương BDBNTM 130 5.2.2 Đặc điểm vi thể tổn thương BDBNTM 131 5.2.3 Đặc điểm DIF 131 5.3 Sự tương hợp LS, MBH DIF chẩn đoán BDBNTM 132 CHƯƠNG 6: KIẾN NGHỊ 133 TÀI LIỆU THAM KHẢO 134 i DANH MỤC TỪ VIẾT TẮT TÊN VIẾT TẮT TÊN ĐẦY ĐỦ BCAT Bạch cầu toan BCĐNTT Bạch cầu đa nhân trung tính BDBNTM Bệnh da bóng nước tự miễn BN Bệnh nhân BP Pemphigoid bóng nước BSLE Lupus ban đỏ hệ thống thể bóng nước DH Viêm da dạng herpes DIP Pemphigus thuốc Dsg Desmoglein EBA Ly thượng bì bóng nước mắc phải ELISA Điện di hấp phụ miễn dịch gắn men EPF Pemphigus đặc hữu GP Pemphigoid thai kỳ GSE Bệnh đường ruột nhạy cảm gluten HMMD Hố mơ miễn dịch KHV Kính hiển vi ii KT Kháng thể LAD Bệnh IgA đường LPP Lichen phẳng thể bóng nước DIF Miễn dịch huỳnh quang trực tiếp MMP Pemphigoid niêm mạc PE Pemphigus đỏ da PF Pemphigus PH Pemphigus dạng herpes IAP Pemphigus IgA PNP Pemphigus cận ung Pve Pemphigus sùi PV PV TB Tế bào iii DANH MỤC ĐỐI CHIẾU THUẬT NGỮ VIỆT- ANH TỪ TIẾNG VIỆT TỪ TIẾNG ANH Bệnh IgA đường Linear IgA disease Điện di miễn dịch gắn men Enzyme-Linked Immunosorbent Assay Lichen phẳng thể bóng nước Lichen planus pemphigoid Lupus ban đỏ hệ thống thể bóng nước Bullous systemic lupus erythematous Ly thượng bì bóng nước mắc phải Epidermolysis bullosa acquisita Pemphigoid bóng nước Bullous pemphigoid Pemphigoid niêm mạc Mucous membrane pemphigoid Pemphigoid thai kỳ Gestational pemphigoid Pemphigus cận ung Paraneoplastic pemphigus Pemphigus đặc hữu Endemic pemphigus foliaceus Pemphigus dạng herpes Pemphigus herpetiformis Pemphigus đỏ da Pemphigus erythematosus Pemphigus thuốc Drug induced pemphigus Pemphigus IgA Immunoglobulin A pemphigus Pemphigus Pemphigus foliaceus Pemphigus sùi Pemphigus vegetens 135 11 Bektas Meryem, Jolly Puneet, Rubenstein David S (2010), “Apoptotic pathways in pemphigus” Dermatology research and practice, 2010, pp 456841-456841 12 Bernard P., Vaillant L., Labeille B., Bedane C., Arbeille B., et al (1995), “Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions Bullous Diseases French Study Group” Arch Dermatol, 131 (1), pp 48-52 13 Bernett CN, Fong M, Rosario-Collazo JA (2021), "Linear IGA Dermatosis", In: StatPearls, StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC., Treasure Island (FL) 14 Bertram F, Bröcker EB, Zillikens D, Schmidt E (2009), “Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany” J Dtsch Dermatol Ges, (5), pp 434-40 15 Blenkinsopp WK, Haffenden GP, Fry L, Leonard JN (1983), “Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid” Am J Dermatopathol, (6), pp 547-54 16 Bolotin D., Petronic-Rosic V (2011), “Dermatitis herpetiformis Part I Epidemiology, pathogenesis, and clinical presentation” J Am Acad Dermatol, 64 (6), pp 1017-24; quiz 1025-6 17 Brenner Sarah, Goldberg Ilan (2011), “Drug-induced pemphigus” Clinics in Dermatology, 29 (4), pp 455-457 18 Brian JH, Clay JC (2017), Diagnostic pathology: Nonneoplastic dermatology, 2nd Edition, Elsevier, Canada, pp 19 Brick KE, Weaver CH, Lohse CM (2014), “Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009” Journal of the American Academy of Dermatology, 71 (1), pp 92-99 20 Bruckner AL, Fitzpatrick JE, Hashimoto T (2005), “Atypical IgA/IgG pemphigus involving the skin, oral mucosa, and colon in a child: a novel variant of IgA pemphigus?” Pediatr Dermatol, 22 (4), pp 321-7 21 Buch AC, Kumar H, Panicker N, Misal S, Sharma Y, et al (2014), “A Crosssectional Study of Direct Immunofluorescence in the Diagnosis of Immunobullous Dermatoses” Indian J Dermatol, 59 (4), pp 364-8 22 Buijsrogge JJ, Diercks GF, Pas HH, Jonkman MF (2011), “The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy” Br J Dermatol, 165 (1), pp 92-8 136 23 Burrows N P., Bhogal B S., Black M M., Rustin M H., Ishida-Yamamoto A., et al (1993), “Bullous eruption of systemic lupus erythematosus: clinicopathological study of four cases” Br J Dermatol, 128 (3), pp 332-8 a 24 Cahali JB, Kakuda EYS, Santi CG, Maruta CW (2002), “Nail manifestations in pemphigus vulgaris” Revista Hospital das Clínicas, 57, pp 229-234 25 Calonje E, Thomas B, Alexander L, Billings S (2020), “McKee's pathology of the skin with clinical correlations” 26 Camisa C., Sharma H M (1983), “Vesiculobullous systemic lupus erythematosus Report of two cases and a review of the literature” J Am Acad Dermatol, (6), pp 924-33 27 Camisa C (1988), “Vesiculobullous systemic lupus erythematosus A report of four cases” J Am Acad Dermatol, 18 (1 Pt 1), pp 93-100 28 Caproni M., Antiga E., Melani L., Fabbri P., The Italian Group for Cutaneous Immunopathology (2009), “Guidelines for the diagnosis and treatment of dermatitis herpetiformis” Journal of the European Academy of Dermatology and Venereology, 23 (6), pp 633-638 29 Carayannopoulos L, Hexham JM, Capra JD (1996), “Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1” J Exp Med, 183 (4), pp 1579-86 30 Carey B., Setterfield J (2019), “Mucous membrane pemphigoid and oral blistering diseases” Clinical and Experimental Dermatology, 44 (7), pp 732-739 31 Castro R M., Roscoe J T., Sampaio S A (1983), “Brazilian pemphigus foliaceus” Clin Dermatol, (2), pp 22-41 32 Chams-Davatchi C, Valikhani M, Daneshpazhooh M (2005), “Pemphigus: analysis of 1209 cases” Int J Dermatol, 44 (6), pp 470-6 33 Chanprapaph K, Sawatwarakul S, Vachiramon V (2017), “A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients” Lupus, 26 (12), pp 1278-1284 34 Chaudhari S, Mobini N (2015), “Linear IgA Bullous Dermatosis: A Rare Clinicopathologic Entity with an Unusual Presentation” The Journal of clinical and aesthetic dermatology, (10), pp 43-46 35 Chhabra S, Minz RW, Saikia B (2012), “Immunofluorescence in dermatology” Indian J Dermatol Venereol Leprol, 78 (6), pp 677-91 137 36 Chiu HY, Chang CJ, Lin YJ, Tsai TF (2020), “National trends in incidence, mortality, hospitalizations, and expenditures for pemphigus in Taiwan” J Dermatol Sci, 99 (3), pp 203-208 37 Clapé A, Muller C, Gatouillat G (2018), “Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of AntiBP230 Autoantibody” Frontiers in immunology, 9, pp 479-479 38 Contestable J J., Edhegard K D., Meyerle J H (2014), “Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment” Am J Clin Dermatol, 15 (6), pp 517-24 39 Contestable JJ, Edhegard KD, Meyerle JH (2014), “Bullous Systemic Lupus Erythematosus: A Review and Update to Diagnosis and Treatment” American Journal of Clinical Dermatology, 15 (6), pp 517-524 40 Cozzani E, Drosera M, Rebora A (2004), “Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid” Acta Derm Venereol, 84 (5), pp 381-4 41 DE Elder, R Elenitsas, BL Johnson, GF Murphy (2005), "Histology of the skin", In: Murphy GF., Editor Lever’s Histopathology of the Skin 9th ed., PA: Lippincott Williams & Wilkins, Philadelphia 42 de Risi-Pugliese T., Cohen Aubart F., Haroche J., Moguelet P., Grootenboer-Mignot S., et al (2018), “Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases” Semin Arthritis Rheum, 48 (1), pp 83-89 43 Diaz L A., Sampaio S A., Rivitti E A., Martins C R., Cunha P R., et al (1989), “Endemic pemphigus foliaceus (fogo selvagem) I Clinical features and immunopathology” J Am Acad Dermatol, 20 (4), pp 657-69 44 Diercks Gilles F H., Pas Hendri H (2016), "Direct Immunofluorescence Microscopy", In: Marcel F Jonkman, Editor Autoimmune Bullous Diseases: Text and Review, Springer International Publishing, Cham, pp 39-46 45 Eaton D P., Diaz L A., Hans-Filho G., Santos V D., Aoki V., et al (1998), “Comparison of black fly species (Diptera: Simuliidae) on an Amerindian reservation with a high prevalence of fogo selvagem to neighboring disease-free sites in the State of Mato Grosso Sul, Brazil The Cooperative Group on Fogo Selvagem Research” J Med Entomol, 35 (2), pp 120-31 46 Egan CA, Zone JJ (1999), “Linear IgA bullous dermatosis” Int J Dermatol, 38 (11), pp 818-27 138 47 Elston Dirk M., Stratman Erik J., Miller Stanley J (2016), “Skin biopsy: Biopsy issues in specific diseases” Journal of the American Academy of Dermatology, 74 (1), pp 1-16 48 Elston DM, Stratman EJ, Miller SJ (2016), “Skin biopsy: Biopsy issues in specific diseases” Journal of the American Academy of Dermatology, 74 (1), pp 1-16 49 Engineer L, Norton LA, Ahmed AR (2000), “Nail involvement in pemphigus vulgaris” Journal of the American Academy of Dermatology, 43 (3), pp 529-535 50 Erdag G, Qureshi HS, Greer KE “Immunoglobulin A pemphigus involving the perianal skin and oral mucosa: an unusual presentation” Cutis, 80(3), pp 218-20 51 Esmaili N, Chams-Davatchi C, Valikhani M, Daneshpazhooh M (2007), “Pemphigus vulgaris in Iran: a clinical study of 140 cases” International Journal of Dermatology, 46 (11), pp 1166-1170 52 Fernandes KA, Galvis KH, Gomes AC, Vargas TJ (2016), “Linear IgA and IgG bullous dermatosis” An Bras Dermatol, 91 (5 suppl 1), pp 32-34 53 Fisler RE, Saeb M, Liang MG, Howard RM, McKee PH (2003), “Childhood bullous pemphigoid: a clinicopathologic study and review of the literature” Am J Dermatopathol, 25 (3), pp 183-9 54 Fleming T E., Korman N J (2000), “Cicatricial pemphigoid” J Am Acad Dermatol, 43 (4), pp 571-91; quiz 591-4 55 Fortuna G, Salas-Alanis JC, Guidetti E, Marinkovich MP (2012), “A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity?” J Am Acad Dermatol, 66 (6), pp 988-94 Mascaró-Galy JM (2014), “Bullous pemphigoid: clinical practice guidelines” Actas Dermosifiliogr, 105 (4), pp 32846 56 Fuertes de Vega I, Iranzo-Fernández P, 57 Gammon W R., Briggaman R A (1993), “Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder” J Invest Dermatol, 100 (1), pp 28s-34s 58 Gammon W R., Briggaman R A., Inman A O., 3rd, Merritt C C., Wheeler C E., Jr (2003), “Evidence supporting a role for immune complex-mediated inflammation in the pathogenesis of bullous lesions of systemic lupus erythematosus” J Invest Dermatol, 81 (4), pp 320-5 139 59 Gammon W R., Briggaman R A (2010), “Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus Diseases of autoimmunity to type VII collagen” Dermatol Clin, 11 (3), pp 535-47 60 Gammon W R., Briggaman R A (2011), “Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder” J Invest Dermatol, 100 (1), pp 28s-34s 61 Gardner KM, Crawford RI (2018), “Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence” J Cutan Med Surg, 22 (1), pp 22-24 62 Genovese G, Venegoni L, Fanoni D (2019), “Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients” Orphanet Journal of Rare Diseases, 14 (1), pp 115 63 Genovese Giovanni, Di Zenzo Giovanni, Cozzani Emanuele, Berti Emilio, Cugno Massimo, et al (2019), “New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update” Frontiers in Immunology, 10, pp 1506 64 Giurdanella F, Diercks GFH, Jonkman MF, Pas HH (2016), “Laboratory diagnosis of pemphigus: direct immunofluorescence remains the gold standard” British Journal of Dermatology, 175 (1), pp 185-186 65 Grabell Daniel A., Matthews Loderick A., Yancey Kim B., Chong Benjamin F (2015), “Detection of Type VII Collagen Autoantibodies Before the Onset of Bullous Systemic Lupus Erythematosus” JAMA dermatology, 151 (5), pp 539543 66 Grando S A., Bystryn J C., Chernyavsky A I., Frusic-Zlotkin M., Gniadecki R., et al (2009), “Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis” Exp Dermatol, 18 (9), pp 764-70 67 Griffiths Christopher E M., Barker Jonathan, Bleiker Tanya, Chalmers Robert, Creamer Daniel (2016), Rook’s Textbook of Dermatopathology, Willey Blackwell, Oxford, pp 68 Hallaji Z., Mortazavi H., Ashtari S., Nikoo A., Abdollahi M., et al (2016), “Pemphigoid gestationis: Clinical and histologic features of twenty-three patients” International journal of women's dermatology, (2), pp 86-90 69 Hallel-Halevy D., Nadelman C., Chen M., Woodley D T (2001), “Epidermolysis bullosa acquisita: update and review” Clin Dermatol, 19 (6), pp 712-8 140 70 Hammers Christoph M., Stanley John R (2016), “Mechanisms of Disease: Pemphigus and Bullous Pemphigoid” Annual review of pathology, 11, pp 175197 71 Hanan R, Aniek L, Diercks FH (2019), “Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm” American Journal of Clinical Dermatology, 20 (6), pp 847-861 72 Hans-Filho G., Aoki V., Rivitti E., Eaton D P., Lin M S., et al (1999), “Endemic pemphigus foliaceus (fogo selvagem) 1998 The Cooperative Group on Fogo Selvagem Research” Clin Dermatol, 17 (2), pp 225-35; discussion 105-6 73 Hashimoto T, Tsuruta D, Koga H, Ishii N (2016), “Summary of results of serological tests and diagnoses for 4774 cases of various autoimmune bullous diseases consulted to Kurume University” Br J Dermatol, 175 (5), pp 953-965 74 Hashimoto T, Teye K, Hashimoto K, Wozniak K, Ueo D, et al (2018), “Clinical and Immunological Study of 30 Cases With Both IgG and IgA Anti-Keratinocyte Cell Surface Autoantibodies Toward the Definition of Intercellular IgG/IgA Dermatosis” Front Immunol, 9, pp 994 75 Hashimoto T., Teye K., Ishii N (2017), “Clinical and immunological studies of 49 cases of various types of intercellular IgA dermatosis and 13 cases of classical subcorneal pustular dermatosis examined at Kurume University” British Journal of Dermatology, 176 (1), pp 168-175 76 Hashimoto Takashi, Ishii Norito, Ohata Chika, Furumura Minao (2012), “Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease” The Journal of Pathology, 228 (1), pp 1-7 77 Hodge BD, Roach J, Reserva JL, Brodell RT (2018), “The spectrum of histopathologic findings in pemphigoid: Avoiding diagnostic pitfalls” Journal of Cutaneous Pathology, 45 (11), pp 831-838 78 Hussein MR, Ali FM, AE Omar (2007), “Immunohistological analysis of immune cells in blistering skin lesions” Journal of clinical pathology, 60 (1), pp 62-71 79 Ishiko A., Matsunaga Y., Masunaga T., Aiso S., Nishikawa T., et al (2003), “Immunomolecular mapping of adherens junction and desmosomal components in normal human epidermis” Exp Dermatol, 12 (6), pp 747-54 80 Joly P, Richard C, Gilbert D (2000), “Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus” J Am Acad Dermatol, 43 (4), pp 619-26 81 Jonkman Marcel F., Diercks Gilles F H (2016), "How to Take a Biopsy", In: Marcel F Jonkman, Editor Autoimmune Bullous Diseases, Springer, Switzerland 141 82 Jonkman MF (2016), Autoimmune Bullous Diseases, Text and Review, Springer, Switzerland, pp 83 Jowkar F, Sadati MS, Tavana S, Agah MA (2014), “Epidemiology of autoimmune bullous diseases and therapeutic modalities during a 10 year period in Iran” Acta Dermatovenerol Croat, 22 (4), pp 246-9 84 Jung M, Kippes W, Messer G (1999), “Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence” J Am Acad Dermatol, 41 (2 Pt 1), pp 266-8 85 Kalaaji Amer N., Nicolas Marie Eleanore O (2006), Mayo Clinic Atlas of Immunofluorescence in Dermatology, Mayo Clinic Scientific Group, Minnesota, USA, pp 86 Kambi DP, Santosh CS, Sugnua B (2013), “Direct immunofluorescence study in autoimmune bullous disorders of skin” International Journal of Biomedical and Advance Research, 4, pp 610-618 87 Kang Sewon, Amagai Masayuki, Bruckner Anna L., Enk Alexander H., Margolis David J., et al (2019), Fitzpatrick’s Dermatology, 9th Edition, McGraw-Hill Education, New York, pp 88 Kanik Andrew, Li Min, Urmacher Carlos D (2012), "Normal Skin", In: Stacey E Mills, Editor Histology for Pathologists, 4th Edition, Wolters Kluwer, 4th Philadelphia, pp 3-27 89 Kanwar AJ, Sandhu K, Handa S (2004), “Chronic bullous dermatosis of childhood in north India” Pediatr Dermatol, 21 (5), pp 610-2 90 Kappius RH, Ufkes NA, Thiers BH (2021), "Paraneoplastic Pemphigus", In: StatPearls, StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC., Treasure Island (FL) 91 Kenani N, Mebazaa A, Denguezli M (2009), “Childhood linear IgA bullous dermatosis in Tunisia” Pediatr Dermatol, 26 (1), pp 28-33 92 Kettler A H., Bean S F., Duffy J O., Gammon W R (1988), “Systemic lupus erythematosus presenting as a bullous eruption in a child” Arch Dermatol, 124 (7), pp 1083-7 93 Kharfi M, Khaled A, Karaa A (2010), “Linear IgA bullous dermatosis: the more frequent bullous dermatosis of children” Dermatol Online J, 16 (1), pp 94 Kim Jong Hoon, Kim Soo-Chan (2019), “Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa” Frontiers in immunology, 10, pp 1259-1259 142 95 Kridin K, Sagi SZ, Bergman R (2017), “Mortality and Cause of Death in Patients with Pemphigus” Acta Derm Venereol, 97 (5), pp 607-611 96 Kridin K (2018), “Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations” Immunologic Research, 66 (1), pp 6-17 97 Kridin K (2018), “Pemphigus group: overview, epidemiology, mortality, and comorbidities” Immunol Res, 66 (2), pp 255-270 98 Kridin K, Bergman R (2018), “Ethnic variations in the epidemiology of bullous pemphigoid in Israel” International Journal of Dermatology, 57 (1), pp 34-39 99 Kridin K (2018), “Accessible Diagnostic Methods to Differentiate between Epidermolysis Bullosa Acquisita and Other Subepidermal Autoimmune Bullous Diseases” Indian journal of dermatology, 63 (5), pp 445-448 100 Kridin K, Patel PM, Jones VA, Cordova A, Amber KT (2020), “IgA pemphigus: A systematic review” Journal of the American Academy of Dermatology, 82 (6), pp 1386-1392 101 Kridin K, Schmidt E (2021), “Epidemiology of Pemphigus” JID Innovations, (1), pp 100004 102 Langan SM, Smeeth L, Hubbard R (2008), “Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study” BMJ, 337, pp a180 103 Laws Philip M., Heelan Kara, Al-Mohammedi Faisal, Walsh Scott, Shear Neil H (2015), “Pemphigus herpetiformis: a case series and review of the literature” International Journal of Dermatology, 54 (9), pp 1014-1022 104 Laws Phillip, Shear Neil H (2016), "Pemphigus Herpetiformis", In: Naveed Sami, Editor Autoimmune Bullous Diseases: Approach and Management, Springer International Publishing, Cham, pp 41-55 105 Lebe B, Nıflıoğlu G Gül, Seyrek S, Ellıdokuz H (2012), “Evaluation of clinical and histopathologic/direct immunofluorescence diagnosis in autoimmune vesiculobullous dermatitis: utility of direct immunofluorescence” Turk Patoloji Derg, 28 (1), pp 11-6 106 Leivo T, Kiistala U, Vesterinen M (2000), “Re-epithelialization rate and protein expression in the suction-induced wound model: comparison between intact blisters, open wounds and calcipotriol-pretreated open wounds” Br J Dermatol, 142 (5), pp 991-1002 143 107 Liu Z, Giudice GJ, Diaz LA (1997), “A major role for neutrophils in experimental bullous pemphigoid” The Journal of clinical investigation, 100 (5), pp 12561263 108 Livden J K (1980), “Basement membrane zone deposits of immunoglobulins and complement in a patient with pemphigus vulgaris” Dermatologica, 160 (4), pp 236-9 109 Mabrouk D, Ahmed AR (2011), “Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris” Pediatr Dermatol, 28 (5), pp 485-93 110 Maehara Laura de Sena Nogueira, Jonkman Marcel F (2016), "Pemphigus Foliaceus", In: Marcel F Jonkman, Editor Autoimmune Bullous Diseases: Text and Review, Springer International Publishing, Cham, pp 83-93 111 Mahmood T, Haroon T (2017), “Patterns of direct immunofluorescence in subepidermal autoimmune bullous diseases of skin in Lahore, Pakistan” Journal of Pakistan Association of Dermatology, 13, pp 67-71 112 Mahoney M G., Wang Z., Rothenberger K., Koch P J., Amagai M., et al (1999), “Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris” J Clin Invest, 103 (4), pp 461-8 113 Maize JC, Green D, Provost TT (1982), “Pemphigus foliaceus: a case with serologic features of Senear-Usher syndrome and other autoimmune abnormalities” J Am Acad Dermatol, (6), pp 736-41 114 Marazza G, Pham HC, Schärer L (2009), “Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study” Br J Dermatol, 161 (4), pp 861-8 115 Martel P., Joly P (2001), “Pemphigus: autoimmune diseases of keratinocyte's adhesion molecules” Clin Dermatol, 19 (6), pp 662-74 116 Meesala D, Harshavardhan T, Vịayalaxmi Ni (2016), “Review article: Enthralling signs - a key to diagnosis” International Journal of Current Research, (12), pp 42929-42932 117 Mentink LF, Jong MC de, Kloosterhuis GJ, Zuiderveen J, Jonkman MF, et al (2007), “Coexistence of IgA antibodies to desmogleins and in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus” Br J Dermatol, 156 (4), pp 635-41 118 Messias IT de, Kuster LC von, Santamaria J, Kajdacsy-Balla A (1988), “Complement and Antibody Deposition in Brazilian Pemphigus Foliaceus and Correlation of Disease Activity With Circulating Antibodies” Archives of Dermatology, 124 (11), pp 1664-1668 144 119 Micali G, Musumeci ML, Nasca MR (1998), “Epidemiologic analysis and clinical course of 84 consecutive cases of pemphigus in eastern Sicily” Int J Dermatol, 37 (3), pp 197-200 120 Milinković MV, Janković S, Medenica L (2016), “Incidence of autoimmune bullous diseases in Serbia: a 20-year retrospective study” J Dtsch Dermatol Ges, 14 (10), pp 995-1005 121 Mohan K H., Pai S., Rao R., Sripathi H., Prabhu S (2008), “Techniques of immunofluorescence and their significance” Indian J Dermatol Venereol Leprol, 74 (4), pp 415-9 122 Murrell DF (2015), Blistering Diseases Pathogenesis,Treatment, Springer, Berlin, pp - Clinical Features, 123 Mutasim DF, Adams BB (2001), “Immunofluorescence in dermatology” Journal of the American Academy of Dermatology, 45 (6), pp 803-824 124 Mysorekar V, Sumathy T, Shyam PA (2015), “Role of direct immunofluorescence in dermatological disorders” Indian Dermatology Online Journal, (3), pp 172180 125 Mysorekar VV, Sumathy TK, Prasad AL Shyam (2015), “Role of direct immunofluorescence in dermatological disorders” Indian dermatology online journal, (3), pp 172-180 126 Nedosekin D, Wilson KD, Campbell K, Shalin S, Wong HK (2021), “Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab” JAAD case reports, 9, pp 57-60 127 Nguyen ET, Lin SK, Wu JJ (2015), “Pemphigus vulgaris with tense bullae” Perm J, 19 (1), pp 77-8 128 Nishikawa T., Hashimoto T (2000), “Dermatoses with intraepidermal IgA deposits” Clin Dermatol, 18 (3), pp 315-8 129 Ohata C, Ishii N, Koga H, Nakama T (2017), “A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence” British Journal of Dermatology, 177 (1), pp 152-157 130 Oktarina DA, Poot AM, Kramer D, Diercks GH, Jonkman MF, et al (2012), “The IgG “Lupus-Band” Deposition Pattern of Pemphigus Erythematosus: Association With the Desmoglein Ectodomain as Revealed by Cases” Archives of Dermatology, 148 (10), pp 1173-1178 145 131 Otley Clark, Hall Russell P (1990), “Dermatitis Herpetiformis” Dermatologic Clinics, (4), pp 759-769 132 Pablo MI Martinez-De, González-Enseña MA, Vicente A (2007), “Childhood Bullous Pemphigoid: Clinical and Immunological Findings in a Series of Cases” Archives of Dermatology, 143 (2), pp 215-220 133 Patterson JW, Hosler GA (2016), Weedon’s Skin Pathology, 4th Edition, Elsevier, USA, pp 134 Pietkiewicz P, Bowszyc-Dmochowska M, Gornowicz-Porowska J (2018), “Involvement of Nail Apparatus in Pemphigus Vulgaris in Ethnic Poles Is Infrequent” Frontiers in Medicine, (227) 135 Ratnam RV (1988), “IgA Dermatosis in an Adult Chinese Population” International Journal of Dermatology, 27 (1), pp 21-24 136 Reich A, Marcinow K, Bialynicki-Birula R (2011), “The lupus band test in systemic lupus erythematosus patients” Therapeutics and clinical risk management, 7, pp 27-32 137 Reunala T L (2001), “Dermatitis herpetiformis” Clin Dermatol, 19 (6), pp 72836 138 Robinson N D., Hashimoto T., Amagai M., Chan L S (1999), “The new pemphigus variants” J Am Acad Dermatol, 40 (5 Pt 1), pp 649-71; quiz 672-3 139 Romeijn TR, Jonkman MF, Knoppers C, Pas HH, Diercks GF (2017), “Complement in bullous pemphigoid: results from a large observational study” Br J Dermatol, 176 (2), pp 517-519 140 Sadik CD, Schmidt E, Zillikens D, Hashimoto T (2020), “Recent progresses and perspectives in autoimmune bullous diseases” Journal of Allergy and Clinical Immunology, 145 (4), pp 1145-1147 141 Sakaguchi M, Bito T, Oda Y, Kikusawa A, Hashimoto T (2013), “Three Cases of Linear IgA/IgG Bullous Dermatosis Showing IgA and IgG Reactivity With Multiple Antigens, Particularly Laminin-332” JAMA Dermatology, 149 (11), pp 1308-1313 142 Sami N, Ahmed AR (2001), “Penile Pemphigus” Archives of Dermatology, 137 (6), pp 756-758 143 Satyapal S., Amladi S., Jerajani H R (2002), “Evaluation of salt split technique of immunofluorescence in bullous pemphigoid” Indian J Dermatol Venereol Leprol, 68 (6), pp 330-3 146 144 Sävervall Christine, Sand Freja Lærke, Thomsen Simon Francis (2017), “Pemphigoid gestationis: current perspectives” Clinical, cosmetic and investigational dermatology, 10, pp 441-449 145 Schlesinger N, Katz M, Ingber A (2002), “Nail involvement in pemphigus vulgaris” Br J Dermatol, 146 (5), pp 836-9 146 Schmidt E., Zillikens D (2013), “Pemphigoid diseases” Lancet, 381 (9863), pp 320-32 147 Schultz B, Hook K (2019), “Bullous Diseases in Children: A Review of Clinical Features and Treatment Options” Paediatr Drugs, 21 (5), pp 345-356 148 Schwieger-Briel A, Moellmann C, Mattulat B (2014), “Bullous pemphigoid in infants: characteristics, diagnosis and treatment” Orphanet journal of rare diseases, 9, pp 185-185 149 Sheridan AT, Kirtschig G, Wojnarowska F (2000), “Mixed immunobullous disease: is this linear IgA disease?” Australas J Dermatol, 41 (4), pp 219-21 150 Shetty Varsha M., Subramaniam Kumudhini, Rao Raghavendra (2017), “Utility of immunofluorescence in dermatology” Indian dermatology online journal, (1), pp 1-8 151 Sladden Chris, Kirchhof Mark G., Crawford Richard I (2014), “Biopsy Location for Direct Immunofluorescence in Patients with Suspected Bullous Pemphigoid Impacts Probability of a Positive Test Result” Journal of Cutaneous Medicine and Surgery, 18 (6), pp 392-396 152 Smoller BR, Woodley DT (1992), “Differences in direct immunofluorescence staining patterns in epidermolysis bullosa acquisita and bullous pemphigoid” J Am Acad Dermatol, 27 (5 Pt 1), pp 674-8 153 Sokol Ena (2016), "Structure of Desmosomes", In: Marcel F Jonkman, Editor Autoimmune Bullous Diseases: Text and Review, Springer International Publishing, Cham, pp 65-69 154 Stieger M, Pelivani N, Ramelet AA, Beltraminelli H, Borradori H (2013), “Penile erosions as first manifestation of pemphigus vulgaris: a misleading presentation” Acta Derm Venereol, 93 (2), pp 248-9 155 Terra JB, Meijer JM, Jonkman MF, Diercks GF (2013), “The n- vs u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis” Br J Dermatol, 169 (1), pp 100-5 147 156 Tjarks BJ, Billings SD, Ko JS (2018), “Efficacy of Triaging Direct Immunofluorescence in Intraepidermal Bullous Dermatoses” Am J Dermatopathol, 40 (1), pp 24-29 157 Toosi S, Collins JW, Lohse CM, Lehman JS (2016), “Clinicopathologic features of IgG/IgA pemphigus in comparison with classic (IgG) and IgA pemphigus” Int J Dermatol, 55 (4), pp e184-90 158 Trattner A, Hodak E, Ingber A, Sandbank M (1989), “'Jewel-like' blisters in bullous pemphigoid” J Am Acad Dermatol, 21 (3 Pt 1), pp 583-4 159 Tsuruta D, Ishii N, Hamada T, Hashimoto T (2011), “IgA pemphigus” Clin Dermatol, 29 (4), pp 437-42 160 Turcan Iana, Jonkman Marcel F (2016), "Structure of Hemidesmosomes and the Epidermal Basement Membrane Zone", In: Marcel F Jonkman, Editor Autoimmune Bullous Diseases: Text and Review, Springer International Publishing, Cham, pp 113-117 161 Ujiie H, Nishie W, Shimizu H (2011), “Pathogenesis of Bullous Pemphigoid” Dermatologic Clinics, 29 (3), pp 439-446 162 Uzun S, Durdu M, Akman A (2006), “Pemphigus in the Mediterranean region of Turkey: a study of 148 cases” Int J Dermatol, 45 (5), pp 523-8 163 Van L, Browning JC, Krishnan RS, Kenner-Bell BM, Hsu S (2008), “Dermatitis herpetiformis: potential for confusion with linear IgA bullous dermatosis on direct immunofluorescence” Dermatol Online J, 14 (1), pp 21 164 Vassileva S (2004), “Bullous systemic lupus erythematosus” Clinics in Dermatology, 22 (2), pp 129-138 165 Vodegel Robert M., de Jong Marcelus C J M., Meijer Hillegonda J., Weytingh Marijn B., Pas Hendri H., et al (2004), “Enhanced diagnostic immunofluorescence using biopsies transported in saline” BMC dermatology, 4, pp 10-10 166 Wang Y M., Mao X M., Zhao W L., Wang Y H., Zuo Y G., et al (2020), “The clinical, immunological and pathological features for relapse of pemphigus herpetiformis: a univariate analysis of 26 cases” British Journal of Dermatology, 182 (3), pp 802-804 167 Wertenteil S, Garg A, Strunk A, Alloo A (2019), “Prevalence estimates for pemphigoid in the United States: A sex-adjusted and age-adjusted population analysis” J Am Acad Dermatol, 80 (3), pp 655-659 148 168 Weston WL, Morelli JG, Huff JC (1997), “Misdiagnosis, Treatments, and Outcomes in the Immunobullous Diseases in Children” Pediatric Dermatology, 14 (4), pp 264-272 169 Wieczorek Marta, Czernik Annette (2016), “Paraneoplastic pemphigus: a short review” Clinical, cosmetic and investigational dermatology, 9, pp 291-295 170 Wojnarowska F, Marsden RA, Bhogal B, Black MM (1988), “Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults: A comparative study demonstrating clinical and immunopathologic overlap” Journal of the American Academy of Dermatology, 19 (5), pp 792-805 171 Wong SN, Chua SH (2002), “Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review” British Journal of Dermatology, 147 (3), pp 476-480 172 Yayli S, Harman M, Baskan EB (2017), “Epidemiology of Pemphigus in Turkey: One-year Prospective Study of 220 Cases” Acta Dermatovenerol Croat, 25 (3), pp 181-188 173 Yogarajah Meera, Sivasambu Bhradeev, Jaffe Eric A (2015), “Bullous Systemic Lupus Erythematosus Associated with Esophagitis Dissecans Superficialis” Case Reports in Rheumatology, 2015, pp 930683 174 Zaraa I, Kerkeni N, Ishak F, Zribi H, Euch D El, et al (2011), “Spectrum of autoimmune blistering dermatoses in Tunisia: an 11-year study and a review of the literature” Int J Dermatol, 50 (8), pp 939-44 ... phẫu bệnh miễn dịch huỳnh quang trực tiếp chẩn đoán bệnh da bóng nước tự miễn? ?? nhằm mục tiêu: Mô tả số đặc điểm lâm sàng bệnh da bóng nước tự miễn Khảo sát đặc điểm giải phẫu bệnh DIF số BDBNTM... bệnh học chẩn đốn BDBNTM, chúng tơi đặt câu hỏi “Các đặc điểm giải phẫu bệnh DIF có vai trị chẩn đốn bệnh da bóng nước tự miễn? ” Vì chúng tơi thực đề tài ? ?Nghiên cứu đặc điểm giải phẫu bệnh miễn. .. DỤC VÀ ĐÀO TẠO BỘ Y TẾ ĐẠI HỌC Y DƯỢC THÀNH PHỐ HỒ CHÍ MINH -oOo - LÊ THỊ ÁI NHÂN NGHIÊN CỨU ĐẶC ĐIỂM GIẢI PHẪU BỆNH VÀ MIỄN DỊCH HUỲNH QUANG TRỰC TIẾP TRONG CHẨN ĐỐN BỆNH DA BĨNG NƯỚC TỰ MIỄN